Trials / Conditions / Community-Acquired Bacterial Pneumonia (CABP)
Community-Acquired Bacterial Pneumonia (CABP)
3 registered clinical trials studyying Community-Acquired Bacterial Pneumonia (CABP).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase II Study of Oral Nafithromycin in CABP NCT02903836 | Wockhardt | Phase 2 |
| Withdrawn | Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia NCT01666743 | Forest Laboratories | Phase 4 |
| Terminated | Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring H NCT01198626 | Furiex Pharmaceuticals, Inc | Phase 2 |